SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001654954-23-012687
Filing Date
2023-10-06
Accepted
2023-10-06 11:33:19
Documents
9
Period of Report
2023-10-05

Document Format Files

Seq Description Document Type Size
1 FORM 6-K ipii_6k.htm 6-K 13274
2 PROXY FOR COMMON ipii_ex991.htm EX-99.1 18883
3 ANNUAL MEETING ipii_ex992.htm EX-99.2 377313
4 CONFIRMATION OF MAILING ipii_ex993.htm EX-99.3 5897
5 NOTICE-AND-ACCESS ipii_ex994.htm EX-99.4 10156
6 ipii_ex993img4.jpg GRAPHIC 1427
7 ipii_ex993img5.jpg GRAPHIC 1124
8 ipii_ex992img3.jpg GRAPHIC 11000
9 ipii_ex992img4.jpg GRAPHIC 27485
  Complete submission text file 0001654954-23-012687.txt   483621
Mailing Address 30 WORCESTER ROAD TORONTO A6 M9W 5X2
Business Address 30 WORCESTER ROAD TORONTO A6 M9W 5X2 416-798-3001
Intellipharmaceutics International Inc. (Filer) CIK: 0001474835 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1130
Type: 6-K | Act: 34 | File No.: 000-53805 | Film No.: 231313229
SIC: 2834 Pharmaceutical Preparations